Search

everythinglearnresearchcommunity

for

Search:↓

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

We need better research to improve alopecia treatment and patient care.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Fat tissue stem cells may help increase hair growth.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

Bleaching hair damages protein structure, especially keratin, leading to weakened hair.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.